Welcome to our dedicated page for Stryker Corporation news (Ticker: SYK), a resource for investors and traders seeking the latest updates and insights on Stryker Corporation stock.
Stryker Corporation, based in Kalamazoo, Michigan, is an American multinational renowned for its groundbreaking medical technologies. The company designs, manufactures, and markets a wide array of medical equipment and devices that play critical roles in healthcare settings around the globe.
Stryker's comprehensive product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds, gurneys, and spinal devices. The company is a dominant force in the medical sector, holding a top-three position in reconstructive orthopedic implants and leading in operating room equipment.
In the most recent financial updates, Stryker reported impressive operating results for the fourth quarter and the full year of 2023. With organic sales growth exceeding 11% and surpassing $20 billion in sales, the company has shown robust performance. Kevin Lobo, Chair and CEO, attributes this success to the dedicated teams driving high growth and strong adjusted earnings.
Stryker's influence extends globally, impacting over 150 million patients annually through its work in MedSurg, Neurotechnology, Orthopaedics, and Spine. Just over a quarter of its total revenue is generated from markets outside the United States, highlighting its international presence and reach.
The company continues to innovate and expand its horizons. For instance, Stryker will disclose its financial results for the first quarter of fiscal year 2024 on April 30, 2024. This forthcoming report is anticipated to provide further insights into the company’s financial health and ongoing projects.
For those interested in staying updated, Stryker's press releases and financial disclosures are readily available on their website. The corporation maintains a strong commitment to improving healthcare outcomes and enhancing patient care through its innovative products and services.
Stryker (NYSE:SYK) has declared a quarterly dividend of $0.63 per share, payable on July 30, 2021, for shareholders of record by June 30, 2021. This represents a significant 9.6% increase compared to the previous year, while remaining unchanged from the last quarter. As one of the leading medical technology companies, Stryker is committed to enhancing healthcare outcomes through its innovative products across Orthopaedics, Medical and Surgical, and Neurotechnology sectors.
Stryker reported Q1 2021 results indicating 10.2% increase in net sales to $4.0 billion compared to 2020, despite ongoing impacts from COVID-19. Adjusted EPS rose 4.9% to $1.93, while reported EPS fell 39.2% to $0.79. Orthopaedics saw a 21.4% growth in net sales, but MedSurg remained flat. The company anticipates 8%-10% organic net sales growth for 2021 and adjusted EPS between $9.05 to $9.30, factoring in currency impacts. The integration of Wright Medical is on track.
Stryker (NYSE:SYK) will participate in the Bank of America Securities 2021 Virtual Health Care Conference on May 11, 2021, at 4:15 p.m. ET. Key representatives include Spencer Stiles, Group President, Orthopaedics & Spine; Robert Cohen, President, Digital, Robotics and Enabling Technologies; and Preston Wells, Vice President, Investor Relations. A webcast of the presentation will be available on Stryker's website, where it will also be archived. Stryker is a leader in medical technology, focusing on improving healthcare outcomes through innovative products and services.
Stryker (NYSE:SYK) will host a conference call on April 27, 2021, at 4:30 p.m. ET to discuss its operating results for Q1 2021, ending March 31. The final results will be available at 4:05 p.m. ET on the same day. Participants can join by calling (877) 702-4565 domestically or (647) 689-5532 internationally, using conference ID 8988724. The call will also be streamed live on Stryker's website and archived for later access. A recording will be available from 8 p.m. ET on April 27 until May 4, 2021. More details can be found at www.stryker.com.
Stryker (NYSE:SYK) has announced that its 2021 Annual Meeting of Shareholders will take place virtually on May 5, 2021, at 2:00 PM ET, due to COVID-19 health concerns. Shareholders can access the meeting via a webcast on the company's Investor Relations page or join by phone using the provided conference ID. A recording of the meeting will be available from May 6, 2021. Stryker is recognized as a leading medical technology company focused on innovative products and services across various medical fields, improving healthcare outcomes for patients and hospitals.
Stryker (NYSE:SYK) will participate in the 41st Annual Cowen Health Care Conference on March 2, 2021. The virtual presentation is scheduled for 10:30 a.m. Eastern Time and will feature Preston Wells, Vice President of Investor Relations, and Andy Pierce, Group President of MedSurg & Neurotechnology.
A webcast and replay of the presentation will be accessible on Stryker's website at www.stryker.com.
Stryker is a leading medical technology company focused on improving healthcare outcomes.
Stryker reported a 3.2% increase in Q4 2020 net sales to $4.3 billion but faced a 3.6% decline for the full year, totaling $14.4 billion. Organic net sales dropped 1.1% in Q4 and 4.8% annually, impacted by COVID-19. Adjusted EPS rose 12.9% to $2.81 for Q4, but decreased 10% to $7.43 for the year. The company anticipates an 8-10% organic growth in 2021 and adjusted EPS between $8.80 and $9.20. Challenges include persistent pricing pressures and pandemic effects, but optimism remains for recovery in elective procedures.
Stryker (NYSE:SYK) has acquired OrthoSensor, Inc., a leader in digital technologies for musculoskeletal care, enhancing its offerings in smart sensor technologies for joint replacement. The acquisition aims to improve patient outcomes through real-time data and evidence-based treatments using OrthoSensor's innovations like the VERASENSE™ intraoperative sensor and MotionSense™ wearables. This strategic move positions Stryker to strengthen its digital ecosystem and expand its data analytics capabilities, which are essential for advancing patient care in orthopaedics.
Stryker (NYSE:SYK) will host a conference call on January 27, 2021, at 4:30 p.m. ET to discuss its operating results for the quarter ending December 31, 2020. The final results will be released at 4:05 p.m. that same day. Participants can join by dialing (877) 702-4565 domestically or (647) 689-5532 internationally, using conference ID 5283279. A webcast of the call will also be available on Stryker's website and will be archived for later access. Stryker is a leading medical technology company focused on improving healthcare through innovative products and services.
Stryker (NYSE:SYK) has declared a quarterly dividend of $0.63 per share, an increase of 9.6% compared to last year, payable on January 29, 2021 to shareholders recorded by December 31, 2020. This decision aligns with Stryker's capital allocation strategy amidst ongoing financial challenges. CEO Kevin Lobo highlighted their commitment to delivering strong financial results and enhancing shareholder value.
FAQ
What is the current stock price of Stryker Corporation (SYK)?
What is the market cap of Stryker Corporation (SYK)?
What does Stryker Corporation specialize in?
Where is Stryker Corporation headquartered?
How did Stryker perform financially in 2023?
What is the scope of Stryker's global impact?
What are some of the products offered by Stryker?
When will Stryker report its financial results for Q1 2024?
How can I access Stryker's financial reports?
Who should I contact for investor inquiries at Stryker?
What areas does Stryker focus its innovations on?
How can I stay updated with Stryker's latest developments?
